How Long Does Stem Cell Therapy Last?

Stem cell therapy does not last a fixed length of time. How long its effects last depends on the type of therapy, the condition being treated, the source of the cells, and how the body responds. Some patients report relief lasting months to a few years, while others see little durable change. There is no single number that applies across the field.

That answer frustrates people looking for a clean figure. But it is the honest one. Stem cell therapy is not one treatment — it is a category that covers everything from well-established bone marrow transplants to experimental injections marketed for joint pain and aging. The durability of each is different, and the evidence behind each varies enormously.

How Long Does Stem Cell Therapy Last?

There is no universal duration. The lifespan of a stem cell treatment depends almost entirely on which treatment it is.

For hematopoietic stem cell transplant — the established procedure used for certain blood cancers and blood disorders — the transplanted cells can persist for the patient’s lifetime. This is well documented. The donated or harvested stem cells rebuild the blood and immune system, and in many cases they continue producing blood cells indefinitely.

For the injectable “stem cell” treatments sold for knee arthritis, back pain, or general wellness, the picture is very different. Most of these use cells from the patient’s own fat or bone marrow. Some studies suggest modest short-term improvement in pain scores for knee osteoarthritis. But how long any benefit lasts is unclear, and the evidence is limited. Many clinics claim effects lasting a year or more. No large, well-controlled trial has confirmed that timeline.

The gap between these two examples is the single most important thing to understand about this question. One is a decades-old medical procedure with strong evidence. The other is a largely unregulated market with thin evidence. They share a name and little else.

Why the Answer Depends on the Type of Stem Cell Treatment

Stem cells differ by source, potency, and what they are being asked to do.

Hematopoietic stem cells live in bone marrow and cord blood. They naturally rebuild the blood system. When transplanted, they home to the marrow and resume normal function. This is why their effects can be permanent.

Mesenchymal stem cells are found in bone marrow, fat tissue, and other connective tissues. They can become bone, cartilage, and fat cells under the right conditions in a lab. In the body, they appear to act more like signaling cells — releasing factors that may calm inflammation — than like replacement parts. Whether they survive long after injection, and whether they turn into useful tissue, is not well established.

Most commercial clinics inject mesenchymal cells, often from fat. The cells are usually processed and reinjected in the same visit. How many remain alive, how many stay in the joint or tissue, and how long any effect persists are open questions. Some research suggests most injected cells do not survive long in the body. That does not mean they have no effect — even a short-lived signal can trigger a response — but it undercuts the idea of a lasting structural repair.

What the Evidence Shows for Common Uses

Durability claims should be matched against what has actually been studied.

For knee osteoarthritis, several small trials and reviews have looked at mesenchymal cells from bone marrow or fat. Some report reduced pain and improved function at follow-up points ranging from months to a couple of years. The studies are generally small, vary widely in method, and few compare the cells against a placebo injection. The evidence is mixed. It does not support a claim that the treatment reliably lasts a specific number of years.

For blood cancers and blood disorders, the evidence for transplant is strong and long-standing. Graft durability is well characterized, and long-term survival data exist for many conditions.

For cartilage regrowth or joint “repair,” the evidence is much weaker. Some studies show changes on imaging, but whether these translate into durable clinical benefit is not established.

For anti-aging, wellness, and cosmetic claims, there is no clinical evidence that these treatments work or that any effect lasts. The evidence is essentially absent.

What Affects How Long Results Last

Several factors influence durability, though for most uses the science is still catching up.

• Cell source and processing. Cells handled gently and kept viable may behave differently than cells stressed during processing. This is logical but not well quantified in human trials.
• Condition being treated. A disease that continues to damage tissue — like ongoing arthritis — can erode any benefit regardless of the treatment.
• Dose and delivery. How many cells are given and where matters, but optimal dosing is not established for most conditions.
• Patient factors. Age, overall health, and the severity of the condition likely play a role. The specifics are not well defined.
• Whether the cells are the patient’s own or donated. This affects immune response and persistence, and the trade-offs differ by procedure.

None of these factors has been pinned down precisely enough to predict an individual’s outcome. Anyone offering a specific timeline is going beyond what the evidence supports.

Why Some Clinics Promise Effects That Last for Years

Marketing often outruns the science. Many clinics advertise stem cell injections with confident timelines — “results last a year or more” — without citing controlled trials that support those numbers.

In the United States, most injectable stem cell products marketed directly to consumers fall outside the standard drug approval pathway. That means they can be sold without the large clinical trials required for prescription medicines. The FDA has warned about clinics offering unapproved stem cell products and has taken action against some. The agency has stated that unproven treatments marketed for serious conditions can put patients at risk.

This does not mean every clinic is acting in bad faith. It means the claims you see are often not backed by the kind of evidence regulators require for other treatments. A promise of “lasting” results should be treated as a marketing statement, not a clinical finding, unless it is tied to a specific, published, controlled study.

Risks and What to Ask Before Treatment

The risks of stem cell therapy depend heavily on the type. For established transplant, risks are well known and managed by specialists — including infection, immune reactions, and graft complications.

For unproven injectable treatments, the risks are less well characterized. Reported concerns include infection at the injection site, inflammation, and, in some cases, unwanted tissue growth. Because these products are often not subject to the same safety oversight, the full risk profile is not known.

If you are considering a treatment, ask direct questions:

• Is this treatment approved by the FDA for my condition?
• What published, controlled studies support the timeline you are quoting?
• What are the known risks, and how are they monitored?
• Is there a registry tracking outcomes for patients like me?

A clinic that cannot answer these plainly is telling you something important. For conditions with established treatments, talk with a physician who knows your full history before pursuing an unproven option.

The Bottom Line on Durability

Stem cell therapy lasts as long as the evidence for that specific treatment supports — and no longer. For blood and immune system transplants, the effects can be lifelong, and that is well established. For injectable treatments marketed for joints, pain, or aging, the honest answer is that durability is uncertain and often unstudied.

The field is real and advancing. Some applications are proven. Many are not yet. The difference between the two is where the answer to “how long does it last” actually lives.